A new report commissioned by the National Pharmacy Association (NPA) has revealed harsh financial realities faced by community pharmacies in England.
The report by Professor David Taylor of University College London warned that 1000s of community pharmacy closure might take place by 2024 in England if the sector
was not supported with additional funds.
At the launch of the report titled 'Protecting UK Public Interests in NHS Community Pharmacy', Prof Taylor said: "There will be several 1,000s of closures over the
next few years unless we take appropriate action, which doesn't mean to pour money all over it, but it is to fund appropriately when necessary.
"At the moment, if we got a partial collapse in the pharmacy network it would disrupt medicine supply and increase health inequalities… For me, it's missing out on
the future development of better and more accessible care, which would be the tragedy of reducing, harming and damaging the pharmacy network unnecessarily."
In response to a Scottish government consultation, the National Pharmacy Association (NPA) has called for continued investment to develop community pharmacy teams and create additional capacity in existing services.
The consultation examines different ways patients access healthcare services in Scotland and focuses on sources of healthcare other than GPs that exist in the community.
The inquiry was discussed with NPA policy leads across the UK, NPA Scottish members and other Scottish pharmacy stakeholder organisations.
The NPA stated that services delivered during the pandemic has proven the importance of Scotland's 1,258 community pharmacies, and believes additional capacity for existing pharmacy services, and expansion of pharmacy Public Health Services is possible with continued investment from the government.
Chief executive of the Pharmaceutical Services Negotiating Committee Janet Morrison has said government ministers are looking at the future of community
pharmacy in England in a "bigger way" and have a vision to go "beyond the Scotland model".
"I think they believe they're going beyond the Scotland model," she said, in her closing keynote at the 7th Annual Pharmacy Business Conference held in London on
Sunday (May 14).
Giving her views on the latest government funding - worth £645 million - for community pharmacy, the head of pharmacy negotiator, added: "Their thinking is for the
future in a bigger and a more forward-thinking way."
She added it was for the first time that community pharmacy has been seen "as part of primary care in a really fundamental way that gives us hope for the future".
Morrison said the new funding uplift was effectively "for five quarters of activity," arguing that the common condition service won't start before December or early
in the New Year due to the time it would take to get the IT systems up and running to support the rollout.
PHOENIX UK has appointed Harry McQuillan, former CEO of Community Pharmacy Scotland, as Chairman of Numark, a community pharmacy membership organisation.
It has over 3750 members ranging from single store pharmacies to large chains, spread across the 'Four Nations'. The organisation provides its members with the
professional and commercial support they need to deliver exceptional care to local communities.
As Numark Chairman, McQuillan will be front and central of representing the interests of the members, and will help ensure policy makers across the UK understand
fully "the potential of community pharmacy."
Steve Anderson, Group Managing Director, PHOENIX UK, commented: "Harry brings to our Numark partnership an outstanding wealth of experience and understanding of
how community pharmacy can work successfully with government officials and politicians.
Margaret MacRury has stepped down from her role as superintendent director for the Rowlands Pharmacy, which has a community pharmacy network in England,Scotland and Wales with more than 450 branches.
MacRury, who served the role for a decade, will step down next month to focus on the pharmacy contract developments taking place in Scotland, Rowlands said in a statement.
She will start her new role in February 2022.
With MacRury leaving the position, Stephen Thomas, currently her deputy, will take up the role of superintendent for Rowlands. He has been with the multiple for nearly 18 years and has worked side-by-side with MacRury for the last decade.
MacRury stated: "I know Stephen will continue that commitment to protecting patients and promoting the pharmacy sector.
The health secretary, Steve Barclay was asked over the delay of 'Pharmacy First' model in England that was proposed by the Pharmaceutical Services Negotiating
Committee (PSNC) last year, at the Health Committee evidence session held on Tuesday (31 January).
Taiwo Owatemi MP (Chair of the Pharmacy APPG) asked whether he was adhering to his statutory responsibility to ensure continued access to medicines and cited the
CCA's closures in areas of deprivation research.
Barclay replied that the government is 'investing more'. He said, "We put an extra 100 million on top of the 2.6 billion a year we commit to community pharmacy to
expand the range of clinical services. We've got over 2 million patients that have been referred to community pharmacy from NHS."
He further added: "One of the issues I'm very keen on is to explore what more we can do in pharmacy not least given the pressures on GP and the opportunity to look
at what it is currently people go to GPS for where potentially the risk to do more at the pharmacy and we're already doing that."
The Taskforce report recognises the important role of community pharmacy and pharmacy teams, and in particular, the fact that they often have most contact with
individuals who are receiving medication assisted treatment, commented the Royal Pharmaceutical Society (RPS) on the publication of the Scottish Drug Deaths
Taskforce's final report.
The final report published on Thursday (June 21) follows four years of work developing and implementing a programme of actions to tackle the rising number of drug
deaths in Scotland.
RPS, as pharmacy's professional leadership body in Scotland and the rest of Great Britain, has positively engaged with the Taskforce as it carried out its work.
Last year, RPS published 'Pharmacy's role in reducing harm and preventing drugs deaths (Scotland)' which contained 14 key recommendations. Many of the recommended actions within the Taskforce's report align with RPS policy.
Jonathan Burton will receive the 2022 RPS Charter Award for his outstanding work for the Society and the wider profession in promoting the interests of pharmacy.
The award will be presented by the President at a future meeting of Fellows and Members to take place at the Society's Edinburgh office on 22nd March 2023.
Jonathan's main role is as a practising, patient-facing pharmacist within the community in NHS Forth Valley where he uses his advanced practice skills and independent
prescribing qualification to assess and treat acute ENT, dermatology, and respiratory conditions.
He was one of the first community pharmacist prescribers in Scotland and has always been at the forefront of innovation and service development.
Jonathan has demonstrated outstanding commitment and passion for the pharmacy profession throughout his career. He has excelled as a pharmacist in the Right Medicine
Pharmacy group, on local and national committees, in advocacy for the pharmacy profession and as a local and national leader who is highly regarded as an exceptional
role model for the profession.
The voter turnout in England for the Royal Pharmaceutical Society's English Pharmacy Board election dropped to 7.9 per cent this year.
Out of a total of 19,512 eligible individuals, only 1,534 decided to vote.
The RPS English Board received ten nominations for five vacancies this year; therefore an election was conducted. One nomination was received for the three
vacancies on the Welsh Pharmacy Board. Three nominations were received for the three vacancies on the Scottish Pharmacy Board. Therefore, no election was
conducted in pharmacy boards in Wales or Scotland.
RPS president Claire Anderson said: "It's disappointing that the voter turnout in England has dropped to 7.9 from 11.8 per cent in 2021. We have now appointed
an independent review of how RPS members, elected members and stakeholders can feel more engaged and empowered to influence RPS decisions, and eagerly await
its recommendations."
The Society appointed communications agency Luther Pendragon to lead a review into how it can develop and strengthen member participation.
Christie & Co has revealed that Islay Pharmacy, the only pharmacy on the Isle of Islay in Scotland, has been sold for the second time in six years.
The business, which single-handedly serves the island's population of circa 3,200 residents, has been purchased by a husband-and-wife team - Lisa and Simon
Simpson - from South Shields.
Previous owner small group operator, Sanjay Majhu, acquired Islay Pharmacy in April 2018 and grew its turnover from £530,000 to just under £700,000.
He listed it for sale along with Inveraray Pharmacy and Tarbert Pharmacy as part of his initiative to downsize his estate, according to the broker.
"We decided to sell as our strategy was to acquire only within a 100-mile radius of Glasgow and Islay would be more suited for owner-operators.
A Company Chemists' Association (CCA) analysis has shown that 'Pharmacy First' service in England could free up 30m+ GP appointments each year.
It has urged the Government and NHS to be even 'bolder in their ambition and go further and faster'.
The recent 'Delivery plan for recovering access to primary care' announced a 'Pharmacy First' service for England, mirroring similar approaches in Scotland and
Wales.
The association has estimated that with the added capability to supply non-prescription medicines and prescribe additional prescription-only medicines, an ambitious
'Pharmacy First' service could free up 30m+ GP appointments annually.
Harnessing community pharmacies to deliver care for minor health conditions will effectively create 11,000 urgent care centres in England.
The Royal Pharmaceutical Society (RPS) has confirmed it will respond to UK Commission's 'call for evidence' on pharmacy professional leadership.
The commission wants to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from
best practice.
The UK Commission on Pharmacy Professional Leadership has been set up by the chief pharmaceutical officers of England, Scotland, Wales and Northern Ireland. It will
produce recommendations for the future of pharmacy professional leadership in the UK.
The commission is co-chaired by Nigel Clarke, former chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, professor of medical education at
University College London's Medical School.
The commission will be hosting a webinar and has urged the associations and individuals to take part in 'call for evidence' which has been launched to inform and
develop its work.
A webinar in England will take place on Wednesday 7 September 6:30 - 8 pm. In Scotland it will be organised on Tuesday 6 September 7-8:30 pm and in Wales it will be
hosted on Thursday 8 September 7-8:30 pm.
The Royal Pharmaceutical Society (RPS) Director for Scotland Clare Morrison participated in the panel discussion alongside representatives from other health
professional organisations on tackling the workforce crisis at the SNP conference in Aberdeen on 8 October.
At the conference, the Cabinet Secretary for Health and Social Care committed to achieving protected learning time for health professionals. Morrison welcomed the
Cabinet Secretary's statement as fantastic news for pharmacists across Scotland.
"RPS Scotland will follow up the discussion by writing to the Cabinet Secretary to request a meeting to discuss achieving protected learning time, the forthcoming
results of our workforce wellbeing survey, and positive examples of how pharmacy teams have improved the well-being of their teams," said the society.
The Royal Pharmaceutical Society (RPS) has re-elected Andrew Carruthers as chair of RPS Scotland Pharmacy Board.
Andrew is a Medicines Governance pharmacist within NHS Greater Glasgow and Clyde, where he has a clinical commitment to Care of the Elderly. Prior to becoming a
pharmacist, he studied Pharmacology at the University of Glasgow, and maintains a keen interest in pharmacokinetics and research.
In his address for the position, he said: "In my second term I want to continue to support and drive the introduction of RPS Ambassadors and the creation of an
online RPS community."
"As a previous RPS local coordinator, I've seen first-hand that RPS Local events are a great forum to formally support the training and development of local
pharmacists. With input from our members and RPS staff we could share learning, inspire, and enable development, and build a supportive online community for the
profession."
He was the RPS Local Co-ordinator for Greater Glasgow and Clyde for 3 years, then he co-opted on to the Scottish Pharmacy Board (SPB) in 2018 and have been an
active and effective member of the board. He was re-elected to the board in 2021 and he stood and was elected as Chair.
The Royal Pharmaceutical Society (RPS) has announced the results of the elections to vacant positions on the RPS Scottish and English Country Boards that took
place at the meeting on June 18.
The Scottish Pharmacy Board elected Jonathan Burton, FRPharmS, as their new Chair and Audrey Thompson to the RPS Assembly, the organisation's governing body.
Jonathan is a community pharmacist and an independent prescriber affiliated with the Right Medicine Pharmacy group in Stirling. He has played an integral role in
the inception, development and delivery of Pharmacy First services in Scotland.
He is an RPS Fellow and received an MBE in 2018 for services to healthcare. Jonathan is also the recipient of the 2023 RPS Charter Award. He previously served as
Chair of the Scottish Pharmacy Board from 2019 to 2021.
"Serving as Chair is a great privilege," said Jonathan while expressing his delight at being elected as the Chair of the Scottish Pharmacy Board.
Pharmacists, along with workers from other public sector workplaces, marched on 8 September demanding that the Scottish government take all available action
to mitigate the biggest reduction in living standards workers will have experienced for generations.
Pharmacists Defence' Association (PDA) members participated in the Scottish Trade Unions Congress (STUC) march to let the government know that "Scotland demands
better".
Paul Flynn, PDA national officer, said: "Pharmacists will be unwelcomely familiar with diminished purchasing power and a squeeze on household budgets for patients,
colleagues and pharmacists but what we will see this year and into 2023 will make previous experience pale by comparison."
The march organised by STUC saw thousands of workers, activists and concerned individuals march through the centre of Edinburgh's Historic Old Town in good spirits
while bearing flags and banners, chanting, singing, and calling for change in Scotland.
The Scottish government has announced funding to help community pharmacy contractors purchase air extraction equipment for their premises.
The funding will be available to pharmacies that have fitted or committed to fit air extraction equipment on or after 1 April 2020.
The funding is aimed at supporting both staff and patient safety, as pharmacists in Scotland provide face to face healthcare services to people every day.
The investment is seen as an important protection measure against respiratory infections, including Covid-19 transmission, as Scotland begins to open-up again following the pandemic.
A three-year contract has been signed between NHS Education for Scotland (NES) and Pharmaceutical Press, the Royal Pharmaceutical Society's (RPS) knowledge business, to continue the supply of trusted medicines information though MedicinesComplete, to healthcare professionals in Scotland.
The renewed investment from NES demonstrates unequivocal confidence in the publisher and highlights Pharmaceutical Press' ongoing commitment to provide practical and evidence-based guidance, supporting those who prescribe, dispense, and administer medicines. Essential resources include Martindale: The Complete Drug Reference, Palliative Care formulary, Stockley's Drug Interactions and Critical Illness.
Relied on by healthcare professionals globally for use in everyday practice, clear and concise guidance through MedicinesComplete supports confident decision-making
at the point of care.
The Scottish government is planning to publish its review report on use of automated technology in community pharmacies by the end of 2023.
The technology being trialled as part of the pilot includes robotic process automation, automated medicine storage systems, barcode scanners and prescription
collection kiosks.
The evaluation, which started prior to the COVID-19 pandemic, is due to be completed at the end of November 2023.
Patricia Findlay, professor of work and employment relations at the University of Strathclyde, who was commissioned to produce the report, told The
Pharmaceutical Journal that the pilot pharmacies taking part in the scheme are all based in Scotland, but she didn't reveal their names.
The Royal Pharmaceutical Society (RPS) presented the best practice award to a pharmacist from NHS Tayside at an event on May 29 which celebrated pharmacy
practice across Scotland.
The Glasgow event, organised by RPS, brought together pharmacists from across the country to present their own best-practice examples.
These included all sectors of pharmacy, including hospital, GP practices, community and specialist settings.
Delegates at the event were asked to vote for what they considered to be the winning example of best practice. Alex Matos, specialist clinical pharmacist, won the
award for his presentation on 'Implementing Pharmacogenomics in the Stroke Service'.
Alex won a £500 bursary for travel and accommodation to the RPS's annual conference in London, where he has been invited to present on his best practice example.